Wang Xiaodong SEC Filing Summary

Wang Xiaodong, Chair of the Scientific Advisory Board, reported a series of transactions on September 28, 2026, involving BeOne Medicines Ltd. American Depositary Shares (ADS). Initially, 31,028 ADSs were acquired at $36.90 per share. Subsequently, a series of sales occurred, totaling 18,037 ADSs, with prices ranging from $356.94 to $367.23 per share. These sales were conducted under a Rule 10b5-1 trading plan. Following these transactions, Wang Xiaodong directly holds 0 ADSs. Indirectly, through various trusts and entities, holdings include 4,588,113 Ordinary Shares directly and 5,078,163 Ordinary Shares indirectly. Additionally, a stock option to purchase 403,364 Ordinary Shares was granted, increasing the post-transaction holdings to 806,715 Ordinary Shares.